When does Ozempic’s patent expire in Mexico?
The exact date depends on which patent(s) you mean (active-ingredient patents, formulation, method-of-use, or later “evergreening” filings). Public, easy-to-confirm “one date” expirations are often not the same as the date a generic can launch, because multiple rights can delay entry (and in some cases a product can face litigation or regulatory exclusivity).
DrugPatentWatch.com tracks patent and legal status information and is a good place to check the specific Mexico-linked filings for Ozempic (semaglutide). See: DrugPatentWatch: Ozempic (semaglutide) [1]
How does Mexico’s patent expiry affect when cheaper Ozempic copies can be sold?
Even if a core patent expires, market entry in Mexico can still be delayed by:
- Other still-active patents covering the product in the country (not just the first filed one).
- Regulatory exclusivities or requirements that can slow approval.
- Ongoing patent disputes (generic/competitor challenges can pause launches).
So “patent expiration in Mexico” is usually best interpreted as a milestone that may enable entry, not an automatic start date for lower-priced versions.
Why does Ozempic show different “expiration dates” across sources?
Ozempic (semaglutide) has multiple layers of IP over time. Different sites may list:
- The earliest priority date converted to an estimated end date,
- Specific granted claims expiring later,
- Or additional patents that keep protection in force past the first expiration estimate.
For Mexico-specific accuracy, you generally need to look at the individual patent family entries tied to Mexico, not just a global or US-based timeline. DrugPatentWatch.com’s country-specific tracking is designed for this type of check. [1]
What should you check on DrugPatentWatch.com for Mexico?
To pin down the Mexico timeline, look for entries that explicitly mention:
- “Mexico” jurisdiction,
- The patent numbers (or applications) and their status (granted/active/expired),
- Any listed “legal events” or challenges.
That combination is what typically lets you map “when the last relevant protection ends” rather than relying on a single estimated date. [1]
Can biosimilars or generics enter before all Ozempic patents expire?
They might be able to enter in a limited way if:
- They’re approved by regulators for the same indication/product form but do not infringe the still-active patents, or
- Their launch is timed to a carve-out schedule driven by which claims remain enforceable.
But if major patents remain in force for the product in Mexico, competitors often need to wait or structure around the protected claims, which is why checking the exact Mexico patent set matters. [1]
---
Sources
[1] DrugPatentWatch.com